Home / Japan / KYORIN Pharmaceutical Co.,Ltd.
KYORIN Pharmaceutical Co.,Ltd.
Short position disclosed on September 2, 2026.
0.47% of the capital sold short
1 disclosing funds
11 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%2%
Aug 11Aug 18Aug 25Sep 1
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Goldman Sachs International | 0.47% | new | September 2, 2026 |
Get the moves on KYORIN Pharmaceutical Co.,Ltd. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 2, 2026 | Goldman Sachs International | 0.47% | still open |
| September 1, 2026 | Goldman Sachs International | 0.50% | |
| August 31, 2026 | Goldman Sachs International | 0.47% | |
| August 31, 2026 | Citigroup Global Markets Limited | 0.00% | |
| August 28, 2026 | Citigroup Global Markets Limited | 1.10% | |
| August 28, 2026 | Goldman Sachs International | 0.72% | |
| August 27, 2026 | Goldman Sachs International | 0.64% | |
| August 19, 2026 | Citigroup Global Markets Limited | 1.06% | |
| August 17, 2026 | Citigroup Global Markets Limited | 1.18% | |
| August 14, 2026 | Goldman Sachs International | 0.50% | |
| August 4, 2026 | Citigroup Global Markets Limited | 1.20% |
Download 11 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- KLab Inc. 17.64% of the capital sold short
- Towa Corporation 14.20% of the capital sold short
- ReYuu Japan Inc. 12.56% of the capital sold short
- 3-D Matrix,Ltd. 11.82% of the capital sold short
- Sanrio Company,Ltd. 10.58% of the capital sold short
- SHIFT Inc. 10.19% of the capital sold short
- QD Laser,Inc. 10.05% of the capital sold short
- AIMECHATEC,Ltd. 9.66% of the capital sold short
- V Technology Co.,Ltd. 9.25% of the capital sold short
- Tri Chemical Laboratories Inc. 9.24% of the capital sold short
- Oncolys BioPharma Inc. 9.12% of the capital sold short
- Nissan Motor Co.,ltd. 8.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, KYORIN Pharmaceutical Co.,Ltd., source JPX, data as at September 2, 2026, https://www.quivad.com/action/kyorin-pharmaceutical-co-ltd